Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery Risk Development in (Young) adults. Circulation. 1995;92(4):785–9.

Article  CAS  PubMed  Google Scholar 

Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, et al. JCS/JHFS 2018 Guideline on the diagnosis and treatment of Cardiomyopathies. Circ J. 2021;85(9):1590–689.

Article  PubMed  Google Scholar 

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733–79.

Article  PubMed  Google Scholar 

Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of Atrial Fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–24.

Article  CAS  PubMed  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation. 2020;142(25).

Kuck K-H, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KRJ, et al. Cryoballoon or Radiofrequency ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374(23):2235–45.

Article  PubMed  Google Scholar 

Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of Atrial Fibrillation by Ectopic beats originating in the Pulmonary veins. N Engl J Med. 1998;339(10):659–66.

Article  PubMed  Google Scholar 

Zhao D-S, Shen Y, Zhang Q, Lin G, Lu Y-H, Chen B-T, et al. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Europace. 2016;18(4):508–20.

Article  PubMed  Google Scholar 

Hayashi H, Hayashi M, Miyauchi Y, Takahashi K, Uetake S, Tsuboi I, et al. Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Interv Card Electrophysiol. 2014;40(2):153–60.

Article  PubMed  Google Scholar 

Okamatsu H, Ohara T, Kanzaki H, Nakajima I, Miyamoto K, Okamura H, et al. Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for Atrial Fibrillation in patients with hypertrophic cardiomyopathy. Circ J. 2015;79(2):419–24.

Article  PubMed  Google Scholar 

Dinshaw L, Münkler P, Schäffer B, Klatt N, Jungen C, Dickow J et al. Ablation of Atrial Fibrillation in patients with hypertrophic cardiomyopathy: treatment strategy, characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome. J Am Heart Assoc. 2021;10(3).

Higuchi S, Ejima K, Minami Y, Ooyabu K, Iwanami Y, Yagishita D, et al. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart Vessels. 2019;34(3):527–37.

Article  PubMed  Google Scholar 

Creta A, Elliott P, Earley MJ, Dhinoja M, Finlay M, Sporton S, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study. Europace. 2021;23(9):1409–17.

Article  PubMed  Google Scholar 

Santangeli P, Di Biase L, Themistoclakis S, Raviele A, Schweikert RA, Lakkireddy D, et al. Catheter ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6(6):1089–94.

Article  PubMed  Google Scholar 

Castagno D, Di Donna P, Olivotto I, Frontera A, Calò L, Scaglione M, et al. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes. J Cardiovasc Electrophysiol. 2021;32(3):657–66.

Article  PubMed  Google Scholar 

Kimura M, Sasaki S, Owada S, Horiuchi D, Sasaki K, Itoh T, et al. Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study. Heart Rhythm. 2014;11(6):984–91.

Article  PubMed  Google Scholar 

Itoh T, Kimura M, Tomita H, Sasaki S, Owada S, Horiuchi D, et al. Reduced residual conduction gaps and favourable outcome in contact force-guided circumferential pulmonary vein isolation. Europace. 2016;18(4):531–7.

Article  PubMed  Google Scholar 

Cao ZJ, Guo XG, Sun Q, Yang JD, Wei HQ, Zhang S, Ma J. Pulmonary vein isolation implemented by second-generation cryoballoon for treating hypertrophic cardiomyopathy patients with symptomatic atrial fibrillation: a case-control study. J Geriatr Cardiol. 2020;17(8):476–85.

CAS  PubMed  PubMed Central  Google Scholar 

Su W, Kowal R, Kowalski M, Metzner A, Svinarich JT, Wheelan K, Wang P. Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm. 2015;12(7):1658–66.

Article  PubMed  Google Scholar 

Wazni OM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, et al. Cryoballoon ablation as initial therapy for Atrial Fibrillation. N Engl J Med. 2021;384(4):316–24.

Article  CAS  PubMed  Google Scholar 

Kimura M, Kobori A, Nitta J, Hirao K, Shizuta S, Kurita T, et al. Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry. J Interv Card Electrophysiol. 2022;64(3):695–703.

Article  PubMed  PubMed Central  Google Scholar 

Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531–8.

Article  PubMed  Google Scholar 

Masuda M, Inoue K, Tanaka N, Watanabe T, Makino N, Egami Y et al. Long-term impact of additional ablation after pulmonary vein isolation: results from EARNEST-PVI trial. J Am Heart Assoc. 2023;12(17).

Yu HT, Shim J, Park J, Kim I-S, Kim T-H, Uhm J-S et al. Pulmonary vein isolation alone Versus additional Linear ablation in patients with Persistent Atrial Fibrillation converted to Paroxysmal Type with Antiarrhythmic Drug Therapy. Circ Arrhythm Electrophysiol. 2017;10(6).

Yao Y, Hu F, Du Z, He J, Shi H, Zhang J, et al. The value of extensive catheter linear ablation on persistent atrial fibrillation (the CLEAR-AF Study). Int J Cardiol. 2020;316:125–9.

Article  PubMed  Google Scholar 

Inoue K, Hikoso S, Masuda M, Furukawa Y, Hirata A, Egami Y, et al. Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial. Europace. 2021;23(4):565–74.

Article  PubMed  Google Scholar 

Yashiro B, Minami Y, Terajima Y, Hagiwara N. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiol. 2014;63(6):432–7.

Article  PubMed  Google Scholar 

Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;7(3):701–4.

Article  CAS  PubMed  Google Scholar 

Kinjo T, Sasaki S, Horiuchi D, Ishida Y, Tomita H. Dual tachyarrhythmia: ventricular fibrillation induced by atrial tachyarrhythmia in a patient with hypertrophic cardiomyopathy. J Arrhythmia. 2023;40:180–3. https://doi.org/10.1002/joa3.12980.

Article  Google Scholar 

Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503–10.

Article  CAS  PubMed  Google Scholar 

Badertscher P, Knecht S, Spies F, Völlmin G, Schaer B, Schärli N. High-power short-duration ablation index-guided pulmonary vein isolation protocol using a single catheter. J Interv Card Electrophysiol. 2022;65:633–42. https://doi.org/10.1007/s10840-022-01226-9.

Article  PubMed  PubMed Central  Google Scholar